EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240226064A1
SERIAL NO

18616227

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MITSUBISHI TANABE PHARMA CORPORATIONOSAKA-SHI OSAKA 541-8505

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
HAYAMA, Tetsuo Osaka-shi, JP 8 17
HAYASHI, Kouji Osaka-shi, JP 38 436
MATSUDA, Munetomo Osaka-shi, JP 11 20
MIYAZAWA, Tadashi Osaka-shi, JP 12 98
OMURA, Tomoyuki Osaka-shi, JP 15 199
TAKAHASHI, Tomohiro Osaka-shi, JP 169 747

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation